Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Amagai

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Pharmaceutics|February 5, 2021
Topical and Systemic Formulation Options for Cutaneous T Cell LymphomasTaku Fujimura, Ryo Amagai, Yumi Kambayashi, et al.
Case Reports in Oncology|July 17, 2024
CIC-DUX4 Rearranged Sarcoma Presenting in the Skin: Case ReportRyo Amagai, Taku Fujimura, Akira Hashimoto, et al.
The Journal of Dermatology|January 11, 2022
Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapyKentaro Ohuchi, Ryo Amagai, Erika Tamabuchi, et al.
Case Reports in Oncology|January 6, 2023
Serum CCL22 Increased in Advanced Melanoma Patients with Liver Metastases: Report of 5 CasesKentaro Ohuchi, Ryo Amagai, Yumi Kambayashi, et al.
Dermatologic Therapy|June 1, 2020
Successful treatment of CCR4+ mycosis fungoides palmaris et plantaris with mogamulizumab monotherapyTaku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, et al.
Archives of Toxicology|June 27, 2021
Optimization of the IL-2 Luc assay for immunosuppressive drugs: a novel in vitro immunotoxicity test with high sensitivity and predictivityYutaka Kimura, Hitoshi Terui, Chizu Fujimura, et al.
The Journal of Dermatology|December 2, 2020
Possible roles of CXCL13/CXCR5 axis in the development of bullous pemphigoidKentaro Ohuchi, Taku Fujimura, Chunbing Lyu, et al.
Case Reports in Oncology|November 26, 2019
Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined TherapySaaya Yoshida, Taku Fujimura, Yumi Kambayashi, et al.
Dermatologic Therapy|July 30, 2020
Serum CCL22 levels decreased in parallel with disease activity in CCR4-positive mycosis fungoides treated with mogamulizumabKentaro Ohuchi, Taku Fujimura, Chunbing Lyu, et al.
The Journal of Dermatology|March 26, 2019
Three cases of nivolumab therapy-failed advanced melanoma successfully controlled by ipilimumab with intensity-modulated radiotherapyRyo Amagai, Taku Fujimura, Yumi Kambayashi, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Pharmaceutics|February 5, 2021
Topical and Systemic Formulation Options for Cutaneous T Cell LymphomasTaku Fujimura, Ryo Amagai, Yumi Kambayashi, et al.
Case Reports in Oncology|July 17, 2024
CIC-DUX4 Rearranged Sarcoma Presenting in the Skin: Case ReportRyo Amagai, Taku Fujimura, Akira Hashimoto, et al.
The Journal of Dermatology|January 11, 2022
Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapyKentaro Ohuchi, Ryo Amagai, Erika Tamabuchi, et al.
Case Reports in Oncology|January 6, 2023
Serum CCL22 Increased in Advanced Melanoma Patients with Liver Metastases: Report of 5 CasesKentaro Ohuchi, Ryo Amagai, Yumi Kambayashi, et al.
Dermatologic Therapy|June 1, 2020
Successful treatment of CCR4+ mycosis fungoides palmaris et plantaris with mogamulizumab monotherapyTaku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, et al.
Archives of Toxicology|June 27, 2021
Optimization of the IL-2 Luc assay for immunosuppressive drugs: a novel in vitro immunotoxicity test with high sensitivity and predictivityYutaka Kimura, Hitoshi Terui, Chizu Fujimura, et al.
The Journal of Dermatology|December 2, 2020
Possible roles of CXCL13/CXCR5 axis in the development of bullous pemphigoidKentaro Ohuchi, Taku Fujimura, Chunbing Lyu, et al.
Case Reports in Oncology|November 26, 2019
Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined TherapySaaya Yoshida, Taku Fujimura, Yumi Kambayashi, et al.
Dermatologic Therapy|July 30, 2020
Serum CCL22 levels decreased in parallel with disease activity in CCR4-positive mycosis fungoides treated with mogamulizumabKentaro Ohuchi, Taku Fujimura, Chunbing Lyu, et al.
The Journal of Dermatology|March 26, 2019
Three cases of nivolumab therapy-failed advanced melanoma successfully controlled by ipilimumab with intensity-modulated radiotherapyRyo Amagai, Taku Fujimura, Yumi Kambayashi, et al.
Pageof 6